AD Ormerod
Impact in
-
- Dermatology and Skin Diseases
Papers in
-
- Toxin Mechanisms and Immunotoxins 2
- Psoriasis: Treatment and Pathogenesis 2
-
- Dermatology and Skin Diseases 2
- Dermatological and COVID-19 studies 1
- Co-authors
- Catherine Smith (2 shared papers)Phyllis I. Spuls (1 shared paper)Berthold Rzany (1 shared paper)Natalie Reytan (1 shared paper)Alexander Nast (1 shared paper)Aroonsri Priprem (1 shared paper)A.J. Winfield (1 shared paper)Richard B. Warren (1 shared paper)
- Journals
- Journal of Dermatological Treatment (2 papers)Journal of the European Academy of Dermatology and Venereology (1 paper)British Journal of Dermatology (1 paper)Journal of Inflammation (1 paper)Scottish Medical Journal (1 paper)
- Partner nations
- United KingdomNetherlandsGermany
In The Last Decade
AD Ormerod
7 papers receiving 42 citations
Peers
Comparison fields: 5 of 31
- Medical Terminology 1
- Dermatology 15
- Complementary and Manual Therapy 3
- Immunology 22
- Pharmaceutical Science 4
Countries citing papers authored by AD Ormerod
This map shows the geographic impact of AD Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Ormerod more than expected).
Fields of papers citing papers by AD Ormerod
This network shows the impact of papers produced by AD Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Ormerod. The network helps show where AD Ormerod may publish in the future.
Co-authors
The 19 scholars most cited alongside AD Ormerod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 27 | |
| 2 | 2008 | 6 | |
| 3 | 1992 | 3 | |
| 4 | Pimecrolimus cream 1% once-daily maintenance therapy for the prevention of relapse in mild to moderate dermatitis in adults. | 2005 | 2 |
| 5 | Persistence with biologic therapies for the treatment of moderate to severe psoriasis: a prospective observational study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). | 2014 | 2 |
| 6 | 2015 | 2 | |
| 7 | 1998 | 1 |
About AD Ormerod
AD Ormerod is a scholar working on Immunology, Dermatology, Pathology and Forensic Medicine, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 7 papers that have together received 43 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (2 papers), Urticaria and Related Conditions (2 papers), Dermatology and Skin Diseases (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Nail Diseases and Treatments (1 paper), Dermatological and COVID-19 studies (1 paper) and Pesticide Exposure and Toxicity (1 paper). The work is most often cited by research in Medical Terminology (1 citation), Dermatology (15 citations), Complementary and Manual Therapy (3 citations), Immunology (22 citations) and Pharmaceutical Science (4 citations). AD Ormerod has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Catherine Smith, Phyllis I. Spuls, Berthold Rzany, Natalie Reytan, Alexander Nast, Aroonsri Priprem, A.J. Winfield, Richard B. Warren, Sanjay Rajpara and M. Nicolson. Their work appears in journals such as Journal of Dermatological Treatment, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Inflammation and Scottish Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.